BioXcel Therapeutics
BTAI
#10060
Rank
ยฃ7.44 M
Marketcap
ยฃ1.36
Share price
7.24%
Change (1 day)
-96.43%
Change (1 year)

BioXcel Therapeutics (BTAI) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ22.42 Million

According to BioXcel Therapeutics's latest financial reports the company has ยฃ22.42 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioXcel Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ51.19 M-68.03%
2022-12-31ยฃ0.16 B-7.22%
2021-12-31ยฃ0.17 B10.38%
2020-12-31ยฃ0.15 B532.29%
2019-12-31ยฃ24.72 M-26.26%
2018-12-31ยฃ33.53 M5009.32%
2017-12-31ยฃ0.65 M
2016-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.19 B 757.37%๐Ÿ‡บ๐Ÿ‡ธ USA